前列腺动脉栓塞术:单术者159例下尿路症状、尿潴留或血尿患者的中期随访经验
单术者对159例良性前列腺增生所致下尿路症状或前列腺源性难治性血尿患者尝试前列腺动脉栓塞术,技术成功156例;下尿路症状患者国际前列腺症状评分从基线均值22降至术后6个月9.5,生活质量评分从4.6改善至2,勃起功能评分保持稳定;尿潴留患者13/24例成功拔除尿管,前列腺源性难治性血尿患者12/12例止血成功。
要点
- 前列腺动脉栓塞术技术成功156/159例,下尿路症状患者IPSS从基线均值22降至6个月9.5并维持至4年。
- 术后首次MRI前列腺体积缩小百分比与1年IPSS改善百分比相关,基线IPSS越高者3年IPSS改善百分比越大。
- 尿潴留患者13/24例成功拔除尿管,前列腺源性难治性血尿患者12/12例止血成功。
核心结论
- 前列腺动脉栓塞术治疗有症状的良性前列腺增生安全有效;基线IPSS最高及术后首次MRI前列腺体积缩小最明显的患者可能从栓塞中获益最大。
研究设计与样本
- 单术者经验研究,共159例患者尝试前列腺动脉栓塞术,记录手术细节、栓塞前后症状评分及栓塞前后磁共振成像数据,并进行统计分析以确定临床结局和预测临床成功的因素。
诊断标准与关键数值
- 技术成功定义为完成前列腺动脉栓塞术,159例中156例技术成功。
- 下尿路症状患者IPSS从基线均值22降至术后6个月9.5,随后1、2、3、4年分别为10.7、10、11.3、11。
- 生活质量评分从基线4.6降至术后6个月2,随后1、2、3、4年分别为2.2、2.4、3.1、2.5。
- 国际勃起功能指数(IIEF-5)评分保持稳定。
- 尿潴留患者中13/24例经前列腺动脉栓塞术成功拔除尿管,前列腺源性难治性血尿患者12/12例出血得到控制。
临床应用与阅片要点
- 双侧或单侧栓塞术后2年内IPSS无显著差异,单纯良性前列腺增生与良性前列腺增生合并活检证实前列腺癌患者术后3年内IPSS无显著差异。
- 1年时IPSS改善百分比与术后首次MRI前列腺体积缩小百分比相关。
- 3年时IPSS改善百分比与基线IPSS相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To describe the authors' experience with prostate artery embolisation (PAE) to treat lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) or refractory haematuria of prostatic origin (RHOPA).
MATERIALS AND METHODS: PAE was attempted in 159 patients. Procedural details, pre/post-PAE symptom scores, and pre/post-PAE magnetic resonance imaging (MRI) data were recorded. Statistical analysis was performed to determine clinical outcomes and factors predicting clinical success.
RESULTS: Technical success was achieved in 156 patients. In patients with LUTS, the International Prostate Symptom Score (IPSS) improved from a mean of 22 at baseline to 9.5 at 6-months post-PAE, then to 10.7, 10, 11.3, and 11 at 1, 2, 3, and 4 years. The quality of life (QoL) score improved from 4.6 at baseline to 2, 2.2, 2.4, 3.1, and 2.5 at the same time points. The International Index of Erectile Function (IIEF-5) scores remained stable. There was no significant difference in IPSS between bilateral or unilateral embolisation to 2 years, or between BPH alone or BPH with biopsy-proven prostate cancer to 3 years post-PAE. Percentage improvement in IPSS at 1 year correlated with percentage reduction in prostate volume on first post-PAE MRI. Percentage improvement in IPSS at 3 years correlated with initial IPSS. PAE facilitated urinary catheter removal in 13/24 patients in retention. PAE controlled bleeding in 12/12 patients with RHOPA.
CONCLUSION: PAE is safe and effective in the management of symptomatic BPH. Patients with the highest baseline IPSS and reduction in prostate volume on first post-PAE MRI are likely to derive most benefit from embolisation.
引用
- Thulasidasan N, Kok HK, Elhage O, et al. Prostate artery embolisation: an all-comers, single-operator experience in 159 patients with lower urinary tract symptoms, urinary retention, or haematuria with medium-term follow-up. Clin Radiol. 2019. PMID: 30955835. doi:10.1016/j.crad.2019.03.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。